Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 29.

Journal Article

Baretton, G., Dietel, M., Gaiser, T., Kirchner, T., Kreipe, H. H., Quaas, A., Roecken, C., Rueschoff, J., Tannapfel, A., Lordick, F., Al-Batran, S., Hofheinz, R., Lorenzen, S., Moehler, M. and Thuss-Patience, P. (2016). HER2 testing in gastric cancer. Results of ameeting of German experts. Pathologe, 37 (4). S. 361 - 367. NEW YORK: SPRINGER. ISSN 1432-1963

Gaiser, M. R., Orouji, A., Hirsch, D., Bach, M., Kind, P., Helbig, D., Quaas, A., Utikal, J., Marx, A. and Gaiser, T. (2018). MYC Gene Amplification is a rare Event in Atypical Fibroxanthoma and Pleomorphic dermal Sarcoma. J. Dtsch. Dermatol. Ges., 16. S. 13 - 14. HOBOKEN: WILEY. ISSN 1610-0387

Garcia-Marquez, M. A., Thelen, M., Bauer, E., Wennhold, K., Lehmann, J., Keller, D., Gathof, B., Maas, L., George, J., Bruns, C., Quaas, A., von Bergwelt-Baildon, M., Peifer, M. and Schloesser, H. A. (2021). GENOMIC HLA HOMOZYGOSITY IS FREQUENT IN ESOPHAGEAL ADENOCARCINOMA AND RELATED TO LOW IMMUNOGENICITY. J. Immunother. Cancer, 9. S. A1 - 2. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Hewitt, L. C., Inam, I. Z., Saito, Y., Yoshikawa, T., Quaas, A., Hoelscher, A., Bollschweiler, E., Fazzi, G. E., Melotte, V., Langley, R. E., Nankivell, M., Cunningham, D., Allum, W., Hutchins, G. G. and Grabsch, H. I. (2018). Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study. Eur. J. Cancer, 94. S. 104 - 115. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Hewitt, L. C., Inam, I. Z., Yoshikawa, T., Quaas, A., Hoelscher, A., Saito, Y., Fazzi, G., Melotte, V., Langley, R. E., Cunningham, D., Allum, W., Hutch-ins, G. G. and Grabsch, H. I. (2017). No Epstein-Barr Virus Infection and Extremely Rare Mismatch Repair Deficiency in Oesophageal Cancer. J. Pathol., 243. S. S29 - 1. HOBOKEN: WILEY. ISSN 1096-9896

Klein, S., Quaas, A., Buettner, R. and Brinker, K. (2018). A word mining approach to select immune-oncological biomarkers. Virchows Arch., 473. S. S19 - 2. NEW YORK: SPRINGER. ISSN 1432-2307

Lehmann, J., Thelen, M., Schran, S., Preugszat, E., Wennhold, K., Garcia-Marquez, M., Lohneis, P., Loeser, H., Popp, F., Kruger, S., Boeck, S., Ormanns, S., Rudelius, M., von Bergwelt, M., Bruns, C., Quaas, A. and Schloesser, H. (2022). ORGANIZATION, FUNCTION AND GENE EXPRESSION OF TERTIARY LYMPHOID STRUCTURES IN PANCREATIC CANCER RESEMBLES LYMPHOID FOLLICLES IN SECONDARY LYMPHOID ORGANS AND THEIR ABUNDANCE IS RELATED TO SUPERIOR SURVIVAL. J. Immunother. Cancer, 10. S. A13 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Linde, P., Baues, C., Marnitz, S., Rosenbrock, J., Celik, E., Quaas, A., Fischer, T., Schomaecker, K., Drzezga, A., Wester, H. -J and Kobe, C. (2020). (68) Ga-Pentixafor-PET/CT-based Radiation Planning in Patients with Esophageal Cancer. Strahlenther. Onkol., 196 (SUPPL 1). S. S149 - 2. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Lordick, F., Al-Batran, S. E., Hofheinz, R. D., Lorenzen, S., Thuss-Patience, P., Baretton, G. B., Dietel, M., Gaiser, T., Kirchner, T., Kreipe, H. H., Quaas, A., Roecken, C., Rueschoff, J. and Tannapfel, A. (2016). HER2 testing in gastric cancer - results of a German expert meeting. Z. Gastroent., 54 (8). S. 791 - 797. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-7803

Macherey, S., Preuss, S. F., Doerr, F., Groenke, S., Heldwein, M., Quaas, A., Zander, T. and Hekmat, K. (2014). Surgical therapy of lung metastases from head and neck cancer. HNO, 62 (12). S. 893 - 902. NEW YORK: SPRINGER. ISSN 1433-0458

Marquez, Ma Garcia, Thelen, M., Bauer, E., Wennhold, K., Lehmann, J., Keller, D., Maas, L., Nicolik, M., George, J., Zander, T., Schroeder, W., Mueller, P., Bruns, C., Thomas, R., Gathof, B., Quaas, A., Hillmer, A. M., Peifer, M., von Bergwelt-Baildon, M. and Schloesser, H. A. (2022). HEREDITARY HOMOZYGOSITY AND ALLELIC IMBALANCE OF HLA AS COMMON IMMUNE ESCAPE MECHANISMS IN ESOPHAGEAL ADENOCARCINOMA. J. Immunother. Cancer, 10. S. A38 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Meyer, M. F., Arolt, C., Kansy, B. A., Doescher, J., Quaas, A., Beutner, D., Lang, S. and Klussmann, J. P. (2020). Tumor microenvironment in salivary gland carcinomas: Consequences for new therapeutic concepts. HNO, 68 (12). S. 927 - 935. NEW YORK: SPRINGER. ISSN 1433-0458

Meyer, M. F., Kreppel, M., Meinrath, J., Gruunewald, I, Stenner, M., Drebber, U., Quaas, A., Odenthal, M., Semrau, R., Huebbers, C. U., Zoeller, J., Huettenbrink, K-B, Buettner, R. and Beutner, D. (2017). Prediction of outcome by lymph node ratio in patients with parotid gland cancer. Clin. Otolaryngol., 42 (1). S. 98 - 104. HOBOKEN: WILEY. ISSN 1749-4486

Meyer, M. F., Meinrath, J., Seehawer, J., Lechner, A., Odenthal, M., Quaas, A., Semrau, R., Huebbers, C. U., Marnitz, S., Buettner, R. and Beutner, D. (2018). The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma. Clin. Otolaryngol., 43 (1). S. 192 - 199. HOBOKEN: WILEY. ISSN 1749-4486

Nachtsheim, Lisa, Mayer, M., Meyer, M. F., Oesterling, F., Kajueter, H., Arolt, C., Quaas, A., Klussmann, J. P. and Wolber, P. . Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany. J. Cancer Res. Clin. Oncol.. NEW YORK: SPRINGER. ISSN 1432-1335

Ozdemir, B. C., Oertelt-prigione, S., Adjei, A. A., Borchmann, S., Haanen, J. B., Letsch, A., Mir, O., Quaas, A., Verhoeven, R. H. A. and Wagner, A. D. (2022). Investigation of sex and gender differences in oncology gains momentum: ESMO announces the launch of a Gender Medicine Task Force. Ann. Oncol., 33 (2). S. 126 - 129. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Ozretic, L., Wagner, S., Huebbers, C. U., Gattenloehner, S., Klussmann, J. P., Beutner, D., Zander, T., Buettner, R. and Quaas, A. (2016). FGFR1 amplification and co-overexpression of c-MYC in oropharyngeal squamous cell carcinoma. Oral Oncol., 54. S. E7 - 3. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1879-0593

Pasternack, H., Fassunke, J., Plum, P., Chon, S., Merkelbach-Bruse, S., Bruns, C., Perner, S., Hallek, M., Buttner, R., Zander, T., Quaas, A., Weiss, J. and Alakus, H. (2017). Detection of Somatic Alterations in Circulating Cell-free DNA of Esophageal Carcinoma Patients during Primary Staging is Predictive for Post-surgical Tumor Recurrence. J. Mol. Diagn., 19 (2). S. S37 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1943-7811

Quaas, A. (2020). Pathology of gastric cancer Pathophysiology-morphology-molecular pathology-personalized treatment options. Onkologe, 26 (10). S. 901 - 912. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Quaas, A., Schloesser, H., Fuchs, H., Zander, T., Arolt, C., Scheel, A. H., Rueschoff, J., Bruns, C., Buettner, R. and Schroeder, W. . Improved Tissue Processing in Esophageal Adenocarcinoma After Ivor Lewis Esophagectomy Allows Histological Analysis of All Surgically Removed Lymph Nodes with Significant Effects on Nodal UICC Stages. Ann. Surg. Oncol.. NEW YORK: SPRINGER. ISSN 1534-4681

Quaas, A., Waldschmidt, D., Alakus, H., Zander, T., Heydt, C., Goeser, T., Daheim, M., Kasper, P., Plum, P., Bruns, C., Brunn, A., Roth, W., Hartmann, N., Bunck, A., Schmidt, M., Goebel, H., Tharun, L., Buettner, R. and Merkelbach-Bruse, S. (2018). Therapy susceptible germline-related BRCA 1-mutation in a case of metastasized mixed adeno-neuroendocrine carcinoma (MANEC) of the small bowel. BMC Gastroenterol., 18. LONDON: BIOMED CENTRAL LTD. ISSN 1471-230X

Schallenberg, S., Schulte, W., Forster, F., Joerss, C., Quaas, A., Menke, B. and Gerigk, U. (2018). Young female patient with secondary pneumonia: a rare endobronchial tumor. Pneumologe, 15 (4). S. 268 - 272. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1613-6055

Schiffmann, L. M., Brunold, M., Liwschitz, M., Goede, V., Loges, S., Wroblewski, M., Quaas, A., Alakus, H., Stippel, D., Bruns, C. J., Hallek, M., Kashkar, H., Hacker, U. T. and Coutelle, O. (2017). A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition. Br. J. Cancer, 116 (5). S. 600 - 609. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827

Schloesser, H. A., Thelen, M., Lechner, A., Gilles, R., Garcia-Marquez, M., Wennhold, K., Alakus, H., Schroeder, W., Moenig, S., Theurich, S., Shimabukuro-Vornhagen, A., Gathof, B., Drebber, U., Quaas, A., Bruns, C., Hoelscher, A. H. and von Bergwelt-Baildon, M. (2017). Tumor-associated B cells and humoral immune response in esophago-gastric adenocarcinoma. Oncol. Res. Treat., 40. S. 159 - 160. BASEL: KARGER. ISSN 2296-5262

Schoemmel, M., Loeser, H., Kraemer, M., Wagener-Ryczek, S., Hillmer, A., Bruns, C., Thelen, M., Schroeder, W., Zander, T., Lechner, A., Buettner, R., Schloesser, H., Gebauer, F. and Quaas, A. (2021). Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus. Clin. Transl. Oncol., 23 (8). S. 1601 - 1611. CHAM: SPRINGER INT PUBL AG. ISSN 1699-3055

Schran, S., Datta, R., Persa, O., Aguilar, C., Thelen, M., Lehmann, J., Garcia-Marquez, M., Wennhold, K., Quaas, A., Bruns, C., Mauch, C., Loeser, H., Stippel, D. and Schloesser, H. (2021). T- AND B-CELL ABUNDANCE ARE REMARKABLY REDUCED IN THE IMMUNE MICROENVIRONMENT OF POST-TRANSPLANT MALIGNANCIES. J. Immunother. Cancer, 9. S. A7 - 2. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Thelen, M., Keller, D., Lehmann, J., Wennhold, K., Weitz, H., Bauer, E., Gathof, B., Brueggemann, M., Kotrova, M., Quaas, A., Mallmann, C., Chon, S., Hillmer, A. M., Bruns, C., von Bergwelt-Baildon, M., Garcia-Marquez, M. A. and Schloesser, H. A. (2022). IMMUNE RESPONSES AGAINST SHARED ANTIGENS ARE COMMON IN ESOPHAGO-GASTRIC CANCER AND CAN BE ENHANCED USING CD40-ACTIVATED B CELLS. J. Immunother. Cancer, 10. S. A24 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Wolber, P., Mayer, M., Nachtsheim, L., Prinz, J., Klussmann, J. P., Quaas, A. and Arolt, C. (2022). Expression of Mucins in Different Entities of Salivary Gland Cancer: Highest Expression of Mucin-1 in Salivary Duct Carcinoma Mucin-1-highest expression in Salivary Duct Carcinoma. Head Neck Pathol., 16 (3). S. 792 - 802. NEW YORK: SPRINGER. ISSN 1936-0568

Wuerdemann, N., Gueltekin, S. E., Wittekindt, C., Sharma, S. J., Schubotz, A. B., Gattenloehner, S., Tharun, L., Baris, E., Sengueven, B., Yildirim, B., Buettner, R., Speel, E. -J., Wagner, S., Klussmann, J. -P. and Quaas, A. (2018). Expression of Programmed Death-Ligand 1 and 2 (PD-L1/2) on Tumor cells of Oropharyngeal Squamous Cell Carcinoma (OPSCC). Oncol. Res. Treat., 41. S. 95 - 96. BASEL: KARGER. ISSN 2296-5262

This list was generated on Thu Jul 18 01:01:07 2024 CEST.